Suppr超能文献

过氧化物酶体增殖物激活受体-α(PPAR-α)介导的炎症如何影响慢性肾脏病的病理生理学。

How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease.

作者信息

Masenga Sepiso K, Desta Selam, Hatcher Mark, Kirabo Annet, Lee Dexter L

机构信息

HAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Livingstone Campus, Zambia.

Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Curr Res Physiol. 2024 Nov 14;8:100133. doi: 10.1016/j.crphys.2024.100133. eCollection 2025.

Abstract

Chronic kidney disease (CKD) is a major risk factor for death in adults. Inflammation plays a role in the pathogenesis of CKD, but the mechanisms are poorly understood. Peroxisome proliferator-activated receptor alpha (PPAR-α) is a nuclear receptor and one of the three members (PPARα, PPARβ/δ, and PPARγ) of the PPARs that plays an important role in ameliorating pathological processes that accelerate acute and chronic kidney disease. Although other PPARs members are well studied, the role of PPAR-α is not well described and its role in inflammation-mediated chronic disease is not clear. Herein, we review the role of PPAR-α in chronic kidney disease with implications for the immune system.

摘要

慢性肾脏病(CKD)是成人死亡的主要危险因素。炎症在CKD的发病机制中起作用,但其机制尚不清楚。过氧化物酶体增殖物激活受体α(PPAR-α)是一种核受体,也是过氧化物酶体增殖物激活受体(PPARs)的三个成员(PPARα、PPARβ/δ和PPARγ)之一,在改善加速急性和慢性肾脏病的病理过程中起重要作用。尽管其他PPARs成员已得到充分研究,但PPAR-α的作用尚未得到充分描述,其在炎症介导的慢性疾病中的作用也不清楚。在此,我们综述PPAR-α在慢性肾脏病中的作用及其对免疫系统的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7358/11629568/ff6c41ac7acd/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验